Pre-exposure (PrEP)
Pre-exposure Prophylaxis (PrEP)
San Francisco Forum Discusses Condomless Sex and HIV Prevention
- Details
- Category: HIV Prevention
- Published on Thursday, 12 December 2013 00:00
- Written by Liz Highleyman
A standing-room-only crowd packed the house at Magnet in San Francisco's Castro district on December 3 for a Real Talk discussion about condomless sex and HIV prevention. A panel of community members and medical experts considered questions such as: Why do gay and bisexual men have condom-free sex? Are community attitudes around condom use changing? and How do treatment as prevention and pre-exposure prophylaxis (PrEP) factor into the equation?
Support for Adherence Improves PrEP's Protective Effect Against HIV
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 11 October 2013 00:00
- Written by Massachusetts General Hospital
Adherence monitoring and counseling can help people use Truvada pre-exposure prophylaxis (PrEP) consistently, leading to a high degree of protection against HIV infection, according to the latest findings from the Partners PrEP trial, published online September 10, 2013, in PLoS Medicine.
IAS 2013: PrEP Appears Safe for Use in Conception, But May Not Be Necessary
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 19 July 2013 00:00
- Written by Roger Pebody
HIV negative women who wish to become pregnant with their male HIV positive partner can be reassured that pre-exposure prophylaxis (PrEP) appears to be a safe option in terms of maternal and infant outcomes, according to data presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur. But modeling work suggested that if the woman’s partner is already taking HIV treatment and unprotected sex is limited to her fertile days, then the addition of PrEP may not afford any extra benefit.
ICAAC 2013: Many Truvada PrEP Users Are Women and Young People, Survey Finds
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 13 September 2013 00:00
- Written by Gus Cairns
An analysis of nationally representative prescription data revealed that nearly half of people taking tenofovir/emtricitabine (Truvada) for pre-exposure prophylaxis (PrEP) are women, according to a poster presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2013) this week in Denver. The study also found that people using Truvada for HIV prevention were more likely to be under age 25 than those using it for treatment.
IAS 2013: Fem-PrEP Trial May Have Failed Because Participants Used Testing as Prevention
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 19 July 2013 00:00
- Written by Gus Cairns
While the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) featured news from 2 trials of pre-exposure prophylaxis (PrEP) that had positive results, it also featured an analysis of the reasons why another trial may have had a negative one.
More Articles...
- IAS 2013: Bangkok Tenofovir Study and iPrEx Find PrEP Efficacy Is Related to Drug Exposure
- IAS 2013: PrEP Shown Effective for Injection Drug Users [VIDEO]
- IAS 2013: iPrEx Participants Interested in Continuing HIV Pre-exposure Prophylaxis [VIDEO]
- CROI 2013: Women's PrEP Trial Does Not Show HIV Risk Reduction [VIDEO]
Web Design and Development by